Protein powders and shakes contain high amounts of lead, new report says—a pharmacologist explains the data

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer agents—antibody-drug conjugates (ADCs)—can dramatically improve outcomes for patients with early-stage HER2-positive breast cancer.

Doctors and researchers at the University of Pittsburgh and UPMC have developed a new treatment for epilepsy patients who don't respond to medication and aren't candidates for surgery. Their approach, published in Nature Communications, uses deep brain stimulation (DBS) that is tailored to each patient's unique brain wiring.

The "gut microbiome" has become a popular health term in recent years. It's easy to see why, with an abundance of research showing how important the trillions of microbes living in our gut are for health.

The Trump administration announced that Boston-based drugmaker EMD Serono will lower the price of one of its leading fertility drugs as part of a push to make in vitro fertilization (IVF) more affordable.

We often hear the phrase, "You are what you eat." But what if it also applied to your children—even before they're born? Research from the Texas A&M University Health Science Center (Texas A&M Health) suggests it does.

Family caregivers for people with dementia report emotional strain from witnessing personality changes, physical exhaustion from providing intensive supervision, social isolation, and financial hardship. To receive counseling and information, they can call the Alzheimer's Association's free 24/7 telephone helpline to receive a care consultation and help create an action plan.

When it comes to describing what an antioxidant is, it's all in the name: Antioxidants counter oxidants.

There are almost 1.1 million licensed physicians in the United States. That may sound like a lot, but the country has struggled for decades to train enough physicians to meet its needs—and, in particular, to provide care in rural and underserved communities.

California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more affordable for folks with diabetes.

We've known for a long time that women are more likely than men to have migraine attacks.

The Hong Kong University of Science and Technology (HKUST) today launched SmartPath, a comprehensive artificial intelligence (AI) system designed to transform the entire pathology workflow for cancer care.

Minimally invasive endoscopic surgery may be an effective and safe treatment for patients with intracerebral hemorrhage, the most severe type of stroke, according to results from a recent clinical trial published in JAMA Neurology.

About one-third of patients with focal epilepsy, a common form of the neurological disorder, are believed to respond poorly to available therapies. Yet they too may eventually see improvement, if not total relief, from their seizures, a new study shows.

Imagine you are a security guard in one of those casino heist movies where your ability to recognize an emerging crime will depend on whether you notice a subtle change on one of the many security monitors arrayed on your desk. That's a challenge of visual working memory.

When ultra-runners lace up for races that stretch hundreds of miles and days, they're not merely testing their mental grit and muscle strength—they're probing the limits of human biology. Reporting in Current Biology, researchers found that even the most extreme athletes cannot surpass an average "metabolic ceiling" of 2.5 times their basal metabolic rate (BMR) in energy expenditure.

Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells—hard-to-find cells that help cancers spread, come back after treatment and resist therapy. The new approach, which the researchers tested in colon cancer, leveraged artificial intelligence (AI) to identify treatments that can reprogram cancer stem cells, ultimately triggering them to self-destruct.

Current NHS policies designed to improve care for people taking multiple medicines may not be effective, according to new research.

Pre-eclampsia is one of the most serious complications in pregnancy, affecting millions of women and newborns worldwide. Despite intensive research, it has remained unclear what processes in the placenta lead to the disease. Now, a research team led by the Medical University of Vienna has discovered a previously unknown mechanism that plays a decisive role in the development of pre-eclampsia. The results, published in the journal Nature Communications, could open up new possibilities for diagnosis and treatment.